Vimarsana
Biggest News Aggregation in the World

Separately Disclosed News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Separately Disclosed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Separately Disclosed Today - Breaking & Trending Today

Eurofins Scientific : Q1 2024 Trading Update Presentation - Vimarsana News

Eurofins Scientific : Q1 2024 Trading Update Presentation

Published: April 24, 2024

CONFIDENTIAL AND PROPRIETARY - © Eurofins Scientific Ltd, 2024. All rights reserved. This document contains information that is confidential and proprietary to Eurofins Scientific SE...

Source: marketscreener.com
Related Topics:
United StatesServices ProductsConsumer Technology Products TestingBiopharma ServicesForensic ServicesTechnology Product TestingEurofins GroupMaterial SciencesGroup Core BusinessEurofins Scientific Ireland LtdLuxembourg Stock ExchangeEurofins ScientificIncome StatementSeparately DisclosedAnnual ReportConsolidated Financial StatementsPerformance MeasuresCore BusinessFeed TestingNorth AmericaEnvironment TestingTechnology ProductOperating SegmentVitro DiagnosticsTechnology Products Testing
Eurofins' Core Business Organic Growth Momentum Improves in Q3 2023 to 7.6% - Vimarsana News

Eurofins' Core Business Organic Growth Momentum Improves in Q3 2023 to 7.6%

Published: October 24, 2023

LUXEMBOURG, October 24, 2023--Regulatory News: Eurofins Scientific SE (Paris:ERF):

Source: yahoo.com
Related Topics:
United KingdomUnited StatesNew ZealandGilles MartinDiagnostics Center PeekabooGroup Core BusinessEuronext Paris Stock ExchangeBiopharma ServicesSociety Of ToxicologyEuropean ParliamentRegulatory NewsCore BusinessEnvironment TestingNorth AmericaFood TestingBiopharma ProductEurofins DiscoveryEarly GenderSeparately DisclosedOrganic Growth CalculationCash FlowHalf YearNine MonthsFull YearConsolidated Financial Statements
Eurofins Scientific: After a Very Strong 2021, Eurofins Fully Compensates for the Decline in COVID-19 Testing in 2022 and Accelerates the Build-Out of its World-Class Network - Vimarsana News

Eurofins Scientific: After a Very Strong 2021, Eurofins Fully Compensates for the Decline in COVID-19 Testing in 2022 and Accelerates the Build-Out of its World-Class Network

Published: March 1, 2023

Regulatory News: Eurofins Scientific (Paris:ERF): Financial highlights Eurofins delivered a solid performance in FY 2022 despite negative consequences of the war in Ukraine, which started two

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomCzech RepublicSan DiegoNew ZealandAndhra PradeshNorth CarolinaRepublic OfAr RiyaSaudi ArabiaNew South WalesKingdom Of Saudi ArabiaDennis RiedlInpac MedizintechnikEurofins Viracor BiopharmaStirling SquareGilles MartinEurofins PanlabsEurofins ViracorEurofin BiopharmaEurofins TechnologieAsia PacificEurofins GenomaIna Overseas Insurance Company LtdOur Future Health
Eurofins Scientific: Eurofins Posts Record Revenues of €3,412m and Overall Results Well in Excess of Its Objectives in H1 2022 and Increases Its Objectives for H2 and FY 2022 - Vimarsana News

Eurofins Scientific: Eurofins Posts Record Revenues of €3,412m and Overall Results Well in Excess of Its Objectives in H1 2022 and Increases Its Objectives for H2 and FY 2022

Published: July 27, 2022

Regulatory News: Eurofins Scientific SE (Paris:ERF): Revenues increased to a record level of €3,412m in H1 2022, up 4.3% vs. H1 2021, driven by good growth of Eurofins' Core Business (excluding

Source: finanznachrichten.de
Related Topics:
United StatesUnited KingdomCzech RepublicSan DiegoCastellon De La PlanaHo Chi Minh CityH ChíinhRepublic OfStanford UniversityAr RiyaSaudi ArabiaNew South WalesKingdom Of Saudi ArabiaInpac MedizintechnikEurofins Viracor BiopharmaMedizintechnik InpacGilles MartinEurofins ViracorEurofin BiopharmaEurofins TechnologieEurofins IpromaMedische MicrobiologieMaterial SciencesFitch RatingsInfrastructure Programme